RNU7-25P

Across TCGA pan-cancer cohorts, RNU7-25P RNA is linked to patient survival in 5 of 34 cancer types, making it the most broadly survival-associated RNU7-25P data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher RNU7-25P RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated RNU7-25P expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BLCA, LGG, and STAD are the cancer types where RNU7-25P RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	DFS	Tertile	III,IV	0.093	0.575	<.001	60	view →
LGG	OS	Tertile	All	0.173	0.810	<.001	36	view →
STAD	DFS	Tertile	All	0.438	0.654	.005	18	view →
SKCM	OS	Tertile	All	0.179	0.787	<.001	18	view →
ESCA	DFS	Tertile	III,IV	0.591	0.266	.039	6	view →

Pink = unfavorable, green = favorable. Showing the 5 strongest of 5 lineages.

RNU7-25P–BLCA (DFS)

Open the BLCA breakdown →